Clearday, Inc. Stock price

Equities

CLRD

US1847911013

Healthcare Facilities & Services

Delayed OTC Markets 03:59:03 2024-03-27 pm EDT 5-day change 1st Jan Change
0.27 USD -12.90% Intraday chart for Clearday, Inc. -10.00% -70.65%
Sales 2021 12.88M Sales 2022 12.49M Capitalization 10.67M
Net income 2021 -19M Net income 2022 -14M EV / Sales 2021 6.22 x
Net Debt 2021 49.37M Net Debt 2022 44.87M EV / Sales 2022 4.45 x
P/E ratio 2021
-1.11 x
P/E ratio 2022
-0.47 x
Employees 225
Yield 2021 *
-
Yield 2022
-
Free-Float 58.17%
More Fundamentals * Assessed data
Dynamic Chart
Clearday, Inc. Enters into Certain First Amended and Restated Promissory Note CI
Clearday, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Clearday, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Clearday, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Clearday, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Clearday, Inc. Auditor Raises 'Going Concern' Doubt CI
Clearday, Inc. announced that it has received $0.135 million in funding CI
Clearday's Elder Care "AI" Gets Major Vote of Confidence with an Expanded Contract with the Veterans Administration (VA) CI
Clearday, Inc. signed a letter of intent to acquire Two adjacent senior living properties Portfolio in the Southeastern United States for approximately $44 million. CI
Clearday, Inc. announced that it has received $0.6804 million in funding from Mast Hill Management, LLC CI
Clearday, Inc. announced that it expects to receive $0.6804 million in funding from Mast Hill Management, LLC CI
Clearday, Inc.'s Companion Robotics Solution Mitra Selected for Pennsylvania Pilot Program CI
Clearday’s Companion Robotics Solution Mitra Selected for Pennsylvania Pilot Program CI
Clearday, Inc. Announces "Companion Robotics" Chosen as A "Revolutionary Elder Care Solution" by TRECS Institute CI
Clearday, Inc. announced that it has received $0.10425 million in funding from 1800 Diagonal Lending, LLC CI
More news
1 day-12.90%
1 week-10.00%
Current month-23.94%
1 month-45.12%
3 months-73.00%
6 months-64.00%
Current year-70.65%
More quotes
1 week
0.26
Extreme 0.263
0.31
1 month
0.26
Extreme 0.263
0.43
Current year
0.25
Extreme 0.25
1.45
1 year
0.25
Extreme 0.25
1.45
3 years
0.25
Extreme 0.25
5.45
5 years
0.25
Extreme 0.25
5.45
10 years
0.25
Extreme 0.25
5.45
More quotes
Managers TitleAgeSince
Chief Executive Officer 63 21-09-08
Director of Finance/CFO 53 21-09-08
Investor Relations Contact - -
Members of the board TitleAgeSince
Director/Board Member 80 21-09-08
Chief Executive Officer 63 21-09-08
Director of Finance/CFO 53 21-09-08
More insiders
Date Price Change Volume
24-03-27 0.27 -12.90% 9,041
24-03-26 0.31 +17.87% 8,224
24-03-25 0.263 -15.16% 12,519
24-03-21 0.31 +3.33% 6,074
24-03-20 0.3 -3.19% 16,109

Delayed Quote OTC Markets, March 27, 2024 at 03:59 pm EDT

More quotes
Clearday, Inc. is engaged in providing technologies and care solutions. The Company has developed a purpose-built longevity-tech platform that addresses the pressing operational and care gaps in the longevity care market. Its platform leverages its longevity care experience in the challenging senior care venues (Memory and Alzheimer's treatment.) The Company's platform enables a dedicated connection between families and communities that can provide new insights, monitoring, and engagement opportunities through its numerous touchpoints, including live events and therapies, group calls, and management of OT/PT and treatment adherence. Its Clearday Labs develops products and services to support older Americans ability to age in the right place. The Clearday Labs initiatives include the development of digital and robotic services in its Longevity-tech platform. It provides exemplary care for older Americans facing dementia and other lifestyle-limiting physical and cognitive issues.
More about the company
  1. Stock
  2. Equities
  3. Stock Clearday, Inc. - OTC Markets